AMANDA GOLDNER: Open Payments
NPI 1467439851 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 27 payments from 18 companies in 2025. Trend: 2023 $952 · 2024 $801 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $162 |
| Arcutis Biotherapeutics, Inc. | 2 | $115 |
| UCB, Inc. | 3 | $81 |
| ABBVIE INC. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Almirall LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: DUPIXENT, Zoryve, Bimzelx, Rhapsido, Seysara, CIBINQO, General - Pain Management, POTELIGEO.
Industry payments across GA — which companies pay providers there.
